Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Lymphatic Metastasis × NET × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 34 Head & Neck 11 Gynecologic 9 Endocrine 8 Breast 7 Genitourinary 6 Thoracic 4 Dermatologic 2 Other neoplasm 1 NET 1 Lymphoid 1

Conditions

Neuroendocrine Tumors 119 Gastro-enteropancreatic neuroendocrine tumor 15 Pancreatic Neoplasms 12 Neoplasms 11 Stomach Neoplasms 7 Carcinoma, Neuroendocrine 7 Carcinoma, Hepatocellular 7 Carcinoid Tumor 7 Prostatic Neoplasms 6 Lung Neoplasms 6 Breast Neoplasms 6 Thyroid Neoplasms 5 Neoplasm Metastasis 5 Melanoma 5 Gastrointestinal Stromal Tumors 5 Esophageal Neoplasms 5 Colonic Neoplasms 5 Adenoma, Islet Cell 5 Serotonin Syndrome 4 Rectal Neoplasms 4 Pheochromocytoma 4 Paraganglioma 4 Carcinoma 4 Adenocarcinoma 4 Testicular Neoplasms 3 Skin Neoplasms 3 Sarcoma 3 Myeloproliferative Disorders 3 Liver Neoplasms 3 Leukemia 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05246319 2025-02-12

TEGRELE

Central Hospital, Nancy, France

Lymphatic Metastasis, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡